ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag chop disease medicine

The Proteasome: A Powerful Target for Manipulating Protein Levels
John Hines and Craig M. Crews | May 1, 2017 | 10+ min read
The proteasome’s ability to target and degrade specific proteins is proving useful to researchers studying protein function or developing treatments for diseases.
Master of the Cell
Judy Lieberman | Apr 1, 2010 | 10+ min read
By Judy Lieberman Master of the Cell RNA interference, with its powerful promise of therapy for many diseases, may also act as a master regulator of most—if not all—cellular processes. RNA silencing. Computer artwork showing a length of RNA (yellow with red rings) bound to an RNA-induced silencing complex (RISC). © Medi-Mation Ltd / Photo Researchers, Inc. ne of the biggest surprises in biology in the past d
Macrophages Play a Double Role in Cancer
Amanda B. Keener | Apr 1, 2018 | 10+ min read
Macrophages play numerous roles within tumors, leaving cancer researchers with a choice: eliminate the cells or recruit them.
Top 10 Innovations 2015
The Scientist | Dec 1, 2015 | 10+ min read
The newest life-science products making waves in labs and clinics
Inspired by Nature
Daniel Cossins | Aug 1, 2015 | 10+ min read
Researchers are borrowing designs from the natural world to advance biomedicine.
Fighting Fraud With DNA
Bennett Daviss | Jun 20, 2004 | 8 min read
Next time you buy a designer shirt, be sure to check the label. What you don't see may surprise you. Hidden within the ink or fibers of that shirt could lie an authentication device made not of plastic or metal, but of DNA."DNA has become the gold standard, the highest barrier to product counterfeiting, diversion, and piracy," says Julia Hunter, executive vice president of Applied DNA Sciences in Los Angeles. In this case, though, the term gold is both literal and figurative. The International C
Detecting Tumors from Shed DNA
Douglas Steinberg | May 13, 2001 | 7 min read
Medical institutions across the United States will begin recruiting volunteers next month for a study that its investigators and outside observers describe as groundbreaking. They say it is the first large-scale trial to test the feasibility of using DNA shed by tumors to find early-stage cancer. During the three-year government-funded project, researchers will analyze DNA from stool samples to detect patterns characteristic of colorectal cancer (CRC). The study will have two other notable fe

Run a Search

ADVERTISEMENT